About GLP1 Cynergy
Where science meets longevity.
We are a dedicated research collective focused on the intersection of GLP-1 biology, peptide therapeutics, and mitochondrial health. Our goal is to accelerate the understanding of metabolic aging through rigorous science and uncompromised quality.
We bridge cutting-edge peptide research with real-world longevity applications.
Our commitment is to transparency, purity, and the advancement of metabolic science.
Every batch is third-party verified.
·
All research is peer-reviewed.
Science Team
Dr. Elena Voss
Head of Research
Former NIH principal investigator with 15+ years in mitochondrial metabolism and NAD+ biology.
Dr. Marcus Thorne
Peptide Biochemist
Specializes in GLP-1 analog design and peptide stability. Holds 7 patents in metabolic therapeutics.
Dr. Anya Sharma
Longevity Scientist
Focuses on sirtuin activation, epigenetic aging clocks, and translational geroscience.
Prof. David Chen
Metabolic Genomics
Expert in transcriptomics and metabolic network modeling. Affiliate researcher at Stanford.
Lab Standards
Third-Party Tested
Every batch is independently verified for purity, heavy metals, and residual solvents.
≥98% Purity
Our NAD+ and peptide compounds consistently exceed 98% purity via HPLC analysis.
GMP Compliant
Manufactured in FDA-registered, GMP-certified facilities under strict quality control.
Transparent Supply
Full chain-of-custody documentation available. We believe in open science and honesty.